Financials
- Market Capitalization 1.43 B
- Employee 435
- Founded 2005
- CEO N/A
- Website www.xerispharma.com
- Headquarter Illinois, United States
- FIGI BBG012V1MG52
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
—
市销率
4.65
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2189 | MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 20.39 USD | -0.10% | +6.81% | +8.17% | +113.28% | 1.50 B USD | ||
| 2210 | NVAX Novavax, Inc. - Common Stock | 8.67 USD | -2.69% | -7.07% | -5.45% | +23.50% | 1.43 B USD | ||
| 2260 | INBX Inhibrx Biosciences, Inc. - Common Stock | 94.01 USD | +2.00% | -6.92% | -1.17% | +16.67% | 1.38 B USD | ||
| 2311 | ARDX Ardelyx, Inc. - Common Stock | 5.19 USD | +0.97% | -4.77% | -9.58% | +12.10% | 1.28 B USD |